This innovative and engaging symposium will provide in-depth coverage of key issues and guidelines surrounding the management of CV risk beyond statin therapy. Prominent, internationally known faculty will highlight relevant clinical pearls to improve patient management and clinical outcomes.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Clinicians Live: New Opportunities to Reduce Residual Risk Beyond Statin Therapy
This innovative symposium will provide in-depth coverage of key issues & guidelines surrounding the management of CV risk beyond statin therapy.
Live
Meeting
1.50 available credits
Information
May 16, 2019
06:45 PM - 08:15 PM EDT
Turnberry Isle Miami
Royal Ballroom 2, 19999 W Country Club Dr, Aventura, Florida, United States
Share
Share
Share this program on:
Choose a format
Details
Related
Comments
Overview
Program Schedule*
6:45 pm–7:00 pm
Registration & Buffet Dinner
7:00 pm–7:10 pm
Program Overview
7:10 pm–7:25 pm
REDUCE-IT and Other Omega-3 Trials
7:25 pm–7:40 pm
Biologic Basis for EPA Modulation in Reducing ASCVD Events Seen in REDUCE-IT
7:40 pm–7:55 pm
Clinician Live Discussion
7:55 pm–8:10 pm
Q& A with the Audience
8:10 pm–8:25 pm
Challenging Cases for Discussion
8:25 pm–8:30 pm
Closing Comments
8:30 pm
Adjourn*Topics subject to change
Faculty
Sergio Fazio, MD, PhD, Chair
R. Preston Mason, PhD
Michael Miller, MD
Margo B. Minissian, PhD
James A. Underberg, MDLearning Objectives
At the conclusion of this activity, participants should be able to:
- Discuss the results and importance of REDUCE-IT and other recent cardiovascular outcomes trials that reduce ASCVD events beyond statin therapy.
- Describe the potential biologic basis for the reductions in ASCVD events observed in REDUCE-IT.
- Apply evidence-based trial data and guidelines to lifestyle and therapeutic approaches for managing patients with or at high risk of ASCVD events.
- Discuss strategies to improve the knowledge, skills or performance of the healthcare team.
Target Audience
This activity is designed to meet the needs of lipidologists, internists, endocrinologists, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.
Disclaimer
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2019 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
Accreditation and Credit Designation
CME Credit Provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and Medtelligence. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.50 continuing professional education units (CPEUs) for completion of this program/materials. CDR Accredited Provider #NL002.
Pharmacists
Universal Activity Number – JA0007192-9999-19-011-L01-P (Application)
This Activity has been approved for 1.50 contact hour(s) (.150 CEUs) of the Accreditation Council for Pharmacy Education.Nursing
The maximum number of hours awarded for this CE activity is 1.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.Activity Type
Live, ApplicationCriteria for Success
Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.Commercial Support
Supported by an independent educational grant from Amarin Pharma, Inc.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact Milly Marte prior to the live event at mmarte@medtelligence.net.
There is no fee for this educational activity.Sponsorship
This activity is jointly provided by the National Lipid Association in collaboration with Medtelligence.
Related
Syllabus
Show more
Details
Related
Comments
Recommended
Overview
This innovative and engaging symposium will provide in-depth coverage of key issues and guidelines surrounding the management of CV risk beyond statin therapy. Prominent, internationally known faculty will highlight relevant clinical pearls to improve patient management and clinical outcomes.
Program Schedule*
6:45 pm–7:00 pm
Registration & Buffet Dinner
7:00 pm–7:10 pm
Program Overview
7:10 pm–7:25 pm
REDUCE-IT and Other Omega-3 Trials
7:25 pm–7:40 pm
Biologic Basis for EPA Modulation in Reducing ASCVD Events Seen in REDUCE-IT
7:40 pm–7:55 pm
Clinician Live Discussion
7:55 pm–8:10 pm
Q& A with the Audience
8:10 pm–8:25 pm
Challenging Cases for Discussion
8:25 pm–8:30 pm
Closing Comments
8:30 pm
Adjourn*Topics subject to change
Faculty
Sergio Fazio, MD, PhD, Chair
R. Preston Mason, PhD
Michael Miller, MD
Margo B. Minissian, PhD
James A. Underberg, MDLearning Objectives
At the conclusion of this activity, participants should be able to:
- Discuss the results and importance of REDUCE-IT and other recent cardiovascular outcomes trials that reduce ASCVD events beyond statin therapy.
- Describe the potential biologic basis for the reductions in ASCVD events observed in REDUCE-IT.
- Apply evidence-based trial data and guidelines to lifestyle and therapeutic approaches for managing patients with or at high risk of ASCVD events.
- Discuss strategies to improve the knowledge, skills or performance of the healthcare team.
Target Audience
This activity is designed to meet the needs of lipidologists, internists, endocrinologists, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.
Disclaimer
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2019 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
Accreditation and Credit Designation
CME Credit Provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and Medtelligence. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.50 continuing professional education units (CPEUs) for completion of this program/materials. CDR Accredited Provider #NL002.Pharmacists
Universal Activity Number – JA0007192-9999-19-011-L01-P (Application)
This Activity has been approved for 1.50 contact hour(s) (.150 CEUs) of the Accreditation Council for Pharmacy Education.Nursing
The maximum number of hours awarded for this CE activity is 1.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.Activity Type
Live, ApplicationCriteria for Success
Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.Commercial Support
Supported by an independent educational grant from Amarin Pharma, Inc.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact Milly Marte prior to the live event at mmarte@medtelligence.net.
There is no fee for this educational activity.Sponsorship
This activity is jointly provided by the National Lipid Association in collaboration with Medtelligence.
Related
Syllabus
Show more
Facebook Comments
Recommended
Title
Share on ReachMD
Close
Programs 3/5/21
Facebook Comments